##gff-version 3
##sequence-region Q8N3F8 1 863
Q8N3F8	UniProtKB	Chain	1	863	.	.	.	ID=PRO_0000075848;Note=MICAL-like protein 1	
Q8N3F8	UniProtKB	Domain	2	108	.	.	.	Note=Calponin-homology (CH);Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00044	
Q8N3F8	UniProtKB	Domain	162	225	.	.	.	Note=LIM zinc-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00125	
Q8N3F8	UniProtKB	Domain	671	818	.	.	.	Note=bMERB;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU01195	
Q8N3F8	UniProtKB	Region	652	863	.	.	.	Note=Mediates the interaction with RAB13 and RAB35 and intramolecular interaction with the CH domain;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21795389,ECO:0000269|PubMed:21951725;Dbxref=PMID:21795389,PMID:21951725	
Q8N3F8	UniProtKB	Region	700	863	.	.	.	Note=Necessary and sufficient to associate with tubular recycling endosome membranes%2C mediate phosphatidic acid-binding and membrane tubulation	
Q8N3F8	UniProtKB	Coiled coil	682	711	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8N3F8	UniProtKB	Coiled coil	785	830	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q8N3F8	UniProtKB	Motif	425	427	.	.	.	Note=NPF1	
Q8N3F8	UniProtKB	Motif	633	635	.	.	.	Note=NPF2	
Q8N3F8	UniProtKB	Compositional bias	253	667	.	.	.	Note=Pro-rich	
Q8N3F8	UniProtKB	Modified residue	295	295	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N3F8	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q8N3F8	UniProtKB	Modified residue	391	391	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	467	467	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	469	469	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8N3F8	UniProtKB	Modified residue	470	470	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q8N3F8	UniProtKB	Modified residue	471	471	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	484	484	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	486	486	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	578	578	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:20068231,PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	621	621	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q8N3F8	UniProtKB	Modified residue	740	740	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q8BGT6	
Q8N3F8	UniProtKB	Natural variant	519	519	.	.	.	ID=VAR_018262;Note=A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17974005;Dbxref=dbSNP:rs9610875,PMID:17974005	
Q8N3F8	UniProtKB	Natural variant	583	583	.	.	.	ID=VAR_020258;Note=P->L;Dbxref=dbSNP:rs2272829	
Q8N3F8	UniProtKB	Natural variant	685	685	.	.	.	ID=VAR_050158;Note=H->R;Dbxref=dbSNP:rs34834842	
Q8N3F8	UniProtKB	Natural variant	817	817	.	.	.	ID=VAR_036192;Note=In a breast cancer sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q8N3F8	UniProtKB	Mutagenesis	385	387	.	.	.	Note=No effect on interaction with PACSIN2. Loss of interaction with PACSIN2%3B when associated with 480-A--A-483. PLP->ALA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23596323;Dbxref=PMID:23596323	
Q8N3F8	UniProtKB	Mutagenesis	425	427	.	.	.	Note=Partial loss of interaction with EHD1. Complete loss of interaction with EHD1%3B when associated with 633-A--A-635. NPF->APA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19864458;Dbxref=PMID:19864458	
Q8N3F8	UniProtKB	Mutagenesis	428	430	.	.	.	Note=Strongly reduces interaction with EHD1. EEE->AAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20106972;Dbxref=PMID:20106972	
Q8N3F8	UniProtKB	Mutagenesis	480	483	.	.	.	Note=No effect on interaction with PACSIN2. Loss of interaction with PACSIN2%3B when associated with 385-A--A-387. PRAP->ARAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23596323;Dbxref=PMID:23596323	
Q8N3F8	UniProtKB	Mutagenesis	633	635	.	.	.	Note=No effect on interaction with EHD1. Complete loss of interaction with EHD1%3B when associated with 425-A--A-427. NPF->APA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19864458;Dbxref=PMID:19864458	
Q8N3F8	UniProtKB	Mutagenesis	721	726	.	.	.	Note=Altered association with membranes. MLVDWF->AAAAAA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19864458;Dbxref=PMID:19864458	
Q8N3F8	UniProtKB	Sequence conflict	137	137	.	.	.	Note=P->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q8N3F8	UniProtKB	Sequence conflict	212	212	.	.	.	Note=F->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
